Benjamin E Blass

Title: Benjamin E. Blass: Innovator in Pharmaceutical Science

Introduction

Benjamin E. Blass is a notable inventor based in Eagleville, PA, who has made significant contributions to the field of pharmaceutical science. With a remarkable portfolio of 25 patents, Blass has focused on developing innovative treatments for various cancers and other diseases through advanced pharmaceutical compositions.

Latest Patents

Two of his most recent patents include:

1. **Prodrugs of Riluzole and Their Method of Use**: This invention presents pharmaceutical compositions that include substituted riluzole prodrugs. These prodrugs are designed for treating cancers such as melanoma, breast cancer, brain cancer, and prostate cancer. The prodrugs enhance stability to hepatic metabolism and are effectively delivered into systemic circulation through oral administration. They are cleaved to release riluzole in the plasma via enzymatic or general biophysical release processes.

2. **5-Hydroxytryptamine Receptor 7 Activity Modulators and Their Method of Use**: This patent describes functionalized lactone derivatives that exhibit disease-modifying actions in treating diseases associated with the dysregulation of 5-hydroxytryptamine receptor 7 activity. The innovative pharmaceutical compositions developed aim to address various health concerns linked with this receptor.

Career Highlights

Benjamin E. Blass has had a fruitful career, predominantly affiliated with Temple University of the Commonwealth System of Higher Education, where he has likely collaborated with various researchers and scholars to push the boundaries of pharmaceutical innovation. His work focuses on enhancing drug efficacy and safety, making him a respected figure in his field.

Collaborations

Throughout his career, Blass has had notable collaborations with professionals such as Daniel J. Canney and Magid A. Abou-Gharbia. These partnerships showcase the collaborative nature of pharmaceutical research, where diverse expertise can lead to groundbreaking inventions.

Conclusion

In conclusion, Benjamin E. Blass is a pivotal inventor whose work in pharmaceuticals has the potential to significantly impact cancer treatment and other therapeutic areas. His innovative patent portfolio demonstrates his commitment to improving patient outcomes through targeted medicinal chemistry and drug delivery systems.